Seeking Alpha

Shares of Cell Therepautics (CTIC) lose 11.6% in premarket trading after the firm announces that...

Shares of Cell Therepautics (CTIC) lose 11.6% in premarket trading after the firm announces that it entered an agreement where it will sell $20M of its Series 14 preferred shares and warrants in order to purchase common stock in a registered offering to 2 institutional investors.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector